Topical dutasteride for androgenic alopecia: current state and prospects.

• Tác giả: Jayanaraian F M Andrade, Andrew Bakst, Marcílio Cunha-Filho, Guilherme M Gelfuso, Taís Gratieri, Andrew Verbinnen
• Ngôn ngữ: eng
• Thông tin xuất bản: England : Therapeutic delivery , 2025
• Bộ sưu tập: NCBI
• ID: 678043

Tóm tắt

Androgenic alopecia has a high incidence, affecting 80% of men and 50% of women in their lifetimes. Although not a life-threatening disease, it can be a deep psychological burden to patients and still lacks an effective and safe treatment. Dutasteride is a5-alpha-reductase inhibitor approved to treat benign prostatic hyperplasia that is also commonly prescribed